Mochi Healths flat-rate pricing ($99/mo semaglutide, $199/mo tirzepatide) applies at all dose levels
Before escalating dose, review: Injection technique Adherence Caloric intake (liquid calories, grazing, alcohol) Resistance training and lean mass preservation If the patient is metabolically improving and clinically stable, dose escalation is optional
Wegovy works by: Slowing gastric emptying, which prolongs feelings of fullness Acting on appetite centres in the brain to reduce hunger Reducing food intake and caloric consumption Clinical trials have demonstrated that semaglutide, when combined with lifestyle interventions, can lead to significant weight losswith mean reductions of approximately 15% in non-diabetic adults (STEP 1 trial) and around 10% in people with type 2 diabetes (STEP 2 trial) over 68 weeks
We are moving from treating weight to treating the diseases of weight
Rybelsus is only approved for treatment of type 2 diabetes, and not weight loss